Pyridam Farma Tbk PT
IDX:PYFA
Pyridam Farma Tbk PT
Capital Expenditures
Pyridam Farma Tbk PT
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Pyridam Farma Tbk PT
IDX:PYFA
|
Capital Expenditures
-Rp256.6B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-133%
|
CAGR 10-Years
-62%
|
|
|
T
|
Tempo Scan Pacific Tbk PT
IDX:TSPC
|
Capital Expenditures
-Rp509.3B
|
CAGR 3-Years
5%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-5%
|
|
|
Kalbe Farma Tbk PT
IDX:KLBF
|
Capital Expenditures
-Rp819.3B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
10%
|
CAGR 10-Years
1%
|
|
|
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
|
Capital Expenditures
-Rp104.3B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-9%
|
|
|
Soho Global Health Tbk PT
IDX:SOHO
|
Capital Expenditures
-Rp108.4B
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
|
|
Kimia Farma Tbk PT
IDX:KAEF
|
Capital Expenditures
-Rp92.1B
|
CAGR 3-Years
45%
|
CAGR 5-Years
28%
|
CAGR 10-Years
4%
|
|
Pyridam Farma Tbk PT
Glance View
PT Pyridam Farma Tbk engages in the production and development of pharmaceutical medicines, and trading of medical supplies. The company is headquartered in Jakarta, Dki Jakarta and currently employs 1,539 full-time employees. The company went IPO on 2001-10-16. The firm operates through two segments: Pharmaceutical Products and Toll Manufacturing Services, and Medical Device Products. Its business consists of production and/or distribution of modern and traditional medicines and distribution of medical devices, such as laboratory equipment and PCR test kits. The company offers products across consumer health, prescription, pyfaesthetic and biomedilab categories. The company produces various kinds of pharmaceuticals products ranging from antibiotics, vitamins and health supplements. The firm offers its products in the form of effervescent tablets, capsules, caplets, syrups and creams. Its prescription production has several properties, such as anti-infection, anti-inflammatory, anti-parkinsonian, anti-epileptic, and other indications. The company provides toll manufacturing services to produce products owned by the Company’s partner companies in accordance with predetermined specifications.
See Also
What is Pyridam Farma Tbk PT's Capital Expenditures?
Capital Expenditures
-256.6B
IDR
Based on the financial report for Sep 30, 2025, Pyridam Farma Tbk PT's Capital Expenditures amounts to -256.6B IDR.
What is Pyridam Farma Tbk PT's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-62%
Over the last year, the Capital Expenditures growth was -1 132%. The average annual Capital Expenditures growth rates for Pyridam Farma Tbk PT have been -3% over the past three years , -133% over the past five years , and -62% over the past ten years .
